Bird Rock Bio
Backed by leading biotechnology venture investors, Bird Rock Bio's strategy leverages biologic targets with substantial human proof of mechanism for the development of first in class molecules with strong clinical and commercial differentiation. Bird Rock Bio's science team is experienced with translating pioneering research into promising therapeutics with potential deep pharmacoeconomic benefits.
Last updated on
About Bird Rock Bio
Estimated Revenue
$1M-$10MEmployees
11-50Funding / Mkt. Cap
$52MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
PharmaceuticalsSIC Code
80NAICs Code
541711Location
City
La JollaState
CaliforniaCountry
United StatesBird Rock Bio
Find your buyer within Bird Rock Bio